Ultrasonographic evaluation of changes in the muscle architecture of the gastrocnemius with botulinum toxin treatment for lower extremity spasticity in children with cerebral palsy

被引:14
|
作者
Kawano, Akihiro [1 ]
Yanagizono, Taiichiro [1 ]
Kadouchi, Ichiro [1 ]
Umezaki, Tetsuya [1 ]
Chosa, Etsuo [2 ]
机构
[1] Miyazaki Prefecture Ctr Disabled Children, Div Orthoped Surg, 4257-8 Kihara, Kiyotake, Miyazaki 8891601, Japan
[2] Univ Miyazaki, Fac Med, Div Orthoped Surg, Dept Med Sensory & Motor Organs, Miyazaki 8891692, Japan
关键词
MEDIAL GASTROCNEMIUS; FASCICLE LENGTH; IN-VIVO; VOLUME; CONTRACTIONS; RELIABILITY; INJECTION; ATROPHY; BIOPSY;
D O I
10.1016/j.jos.2017.10.012
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Botulinum toxin A treatment involves injecting botulinum toxin A to relax muscle spasticity. Using ultrasonography, this study examined changes in the muscle architecture before and after treatment to evaluate the influence of botulinum toxin A injection on muscles. Methods: The participants included 18 children (mean age, 6.2 years) with cerebral palsy who were treated with botulinum toxin A for lower extremity spasticity and 27 healthy children (mean age, 6.4 years) as a control group. In all cases, botulinum toxin A was injected into the gastrocnemius muscle. The muscle length, muscle width, and pennation angle (which indicates the degree of muscle fiber tone), were measured using B-mode ultrasonography before and 12 weeks after injection. Results: The muscle length and muscle width were shorter in the cerebral palsy group than in the control group. The pennation angle in the cerebral palsy group significantly decreased after injection from 28.2 +/- 3.6 degrees to 25.8 +/- 2.5 degrees in the resting position of the ankle and from 18.6 +/- 2.8 degrees to 15.9 +/- 1.7 degrees in the maximum dorsiflexion position of the ankle. In the control group, the pennation angle was 25.9 +/- 3.2 degrees in the resting position of the ankle and 15.1 +/- 2.5 degrees in the maximum dorsiflexion position of the ankle. The rate of increase of fascicle length during passive movement from the resting position of the ankle to the maximum dorsiflexion position was 143.9% in the cerebral palsy group, which was significantly less than the value of 157.7% in the control group. After botulinum toxin A treatment, the rate of increase of fascicle length in the cerebral palsy group increased to 155.1%. Conclusions: The decrease in the pennation angle after botulinum toxin A treatment is considered to be the result of a reduction of spasticity and subsequent structural changes in flaccid muscle fibers. (C) 2017 The Japanese Orthopaedic Association. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:389 / 393
页数:5
相关论文
共 50 条
  • [31] Lower limb muscle activity in ambulatory children with cerebral palsy before and after the treatment with Botulinum toxin A
    Hesse, S
    Brandl-Hesse, B
    Seidel, U
    Doll, B
    Gregoric, M
    RESTORATIVE NEUROLOGY AND NEUROSCIENCE, 2000, 17 (01) : 1 - 8
  • [32] The effect of botulinum toxin type A treatment of the lower extremity on the level of functional abilities in children with cerebral palsy: evaluation with goal attainment scaling
    Steenbeek, D
    Meester-Delver, A
    Becher, JG
    Lankhorst, GJ
    CLINICAL REHABILITATION, 2005, 19 (03) : 274 - 282
  • [33] The Effect of Botulinum Toxin Injections on Gross Motor Function for Lower Limb Spasticity in Children with Cerebral Palsy
    Choi, Ja Young
    Kim, Seung Ki
    Park, Eun Sook
    TOXINS, 2019, 11 (11)
  • [34] Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes
    Hu, Gwo-Chi
    Chuang, Yao-Chia
    Liu, Jen-Pei
    Chien, Kuo-Liong
    Chen, Yi-Min
    Chen, Ying-Fang
    CLINICAL REHABILITATION, 2009, 23 (01) : 64 - 71
  • [35] Myths and evidence on the use of botulinum toxin: spasticity in adults and in children with cerebral palsy
    Martinez-Castrillo, Juan C.
    Pena-Segura, Jose L.
    Sanz-Cartagena, Pilar
    Alonso-Curco, Xenia
    Arbelo-Gonzalez, Jose M.
    Arriola-Pereda, Gema
    Dolors Coll-Bosch, M.
    Conejero-Casares, Juan A.
    Garcia-Ribes, Ainhoa
    Jauma-Classen, Serge
    Pagonabarraga, Javier
    Vidal-Valls, Joan
    Garcia-Ruiz, Pedro J.
    REVISTA DE NEUROLOGIA, 2017, 64 (10) : 459 - 470
  • [37] Effect of Botulinum Toxin Type A on Functional Mobility in Cerebral Palsy with Lower Limb Spasticity
    Vasudeva, Abhimanyu
    Laisram, Nonica
    Chanu, Asem Rangita
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2018, 12 (05) : YC5 - YC9
  • [38] Upper Extremity Function and Occupational Performance in Children With Spastic Cerebral Palsy Following Lower Extremity Botulinum Toxin Injections
    Keren-Capelovitch, Tal
    Jarus, Tal
    Fattal-Valevski, Aviva
    JOURNAL OF CHILD NEUROLOGY, 2010, 25 (06) : 694 - 700
  • [39] The effects of botulinum toxin (BTX-A) on spasticity of the lower limb and on gait in cerebral palsy
    Preiss, RA
    Condie, DN
    Rowley, DI
    Graham, HK
    JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2003, 85B (07): : 943 - 948
  • [40] BOTULINUM TOXIN TYPE A (INCOBOTULINUMTOXINA) IN CEREBRAL PALSY: COMBINED TREATMENT OF SPASTICITY AND SIALORRHEA
    Kurenkov, Alexey
    Klochkova, Olga
    Kuzenkova, Lydmila
    Bursagova, Bella
    Ashrafova, Ulvija
    TOXICON, 2021, 190 : S44 - S44